# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Jul 9, 2014

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2014-07-09
- Accepted by EDGAR: Jul 9, 2014, 20:48 ET
- Period: 2014-07-09
- Accession: 0000875320-14-000040
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532014000040/a8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532014000040/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532014000040/a8-k.htm

Filed Jul 9, 2014.
Source: SEC EDGAR, the filing index for accession 0000875320-14-000040. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.
